Cerebellar degeneration-related protein 1 expression in fibroblasts of patients affected by down syndrome

References

• Altug-Teber O, Bonin M, Walter M, Mau-Holzmann UA, Dufke A, Stappert H. 2007. Specific transcriptional changes in human fetuses with autosomal trisomies. Cytogenet Genome Res. 119:171–184. doi: https://doi.org/10.1159/000112058
   Google Scholar
• Antonarakis SE, Lyle R, Dermitzakis ET, Reymond A, Deutsch S. 2004. Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet. 5:725–738. doi: https://doi.org/10.1038/nrg1448
   PubMed Web of Science ®Google Scholar
• Birchler JA, Bhadra U, Bhadra MP, Auger DL. 2001. Dosage-dependent gene regulation in multicellular eukaryotes: implications for dosage compensation, aneuploid syndromes, and quantitative traits. Dev Biol. 234:275–288. doi: https://doi.org/10.1006/dbio.2001.0262
   PubMed Web of Science ®Google Scholar
• Bosco P, Spada R, Caniglia S, Salluzzo MG, Salemi M. 2014. Cerebellardegeneration-related autoantigen 1 (CDR1) gene expression in Alzheimer's disease. Neurol Sci. 35:1613–1614. doi: https://doi.org/10.1007/s10072-014-1805-6
   Google Scholar
• Capone GT. 2001. Down syndrome: advances in molecular biology and the neurosciences. J Dev Behav Pediatr. 22:40–59. doi: https://doi.org/10.1097/00004703-200102000-00007
   Google Scholar
• Cartier L, Murphy-Kaulbeck L. 2012. Counselling considerations for prenatal genetic screening. J Obstet Gynaecol. 34(5):489–493.
   Google Scholar
• Celio MR. 1990. Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience. 35:375–475. doi: https://doi.org/10.1016/0306-4522(90)90091-H
   PubMed Web of Science ®Google Scholar
• Chen YT, Rettig WJ, Yenamandra AK, Kozak CA, Chaganti RS, Posner JB, et al. 1990. Cerebellar degeneration-related antigen: a highly conserved neuroectodermal marker mapped to chromosomes X in human and mouse. Proc Natl Acad Sci USA. 87:3077–3081. doi: https://doi.org/10.1073/pnas.87.8.3077
   PubMed Web of Science ®Google Scholar
• Cunningham J, Graus F, Anderson N, Posner JB. 1986. Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration. Neurology. 36:1163–1168. doi: https://doi.org/10.1212/WNL.36.9.1163
   PubMed Web of Science ®Google Scholar
• Dropcho EJ, Chen YT, Posner JB, Old LJ. 1987. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Nat 84:4552–4556. doi: https://doi.org/10.1073/pnas.84.13.4552
   PubMed Web of Science ®Google Scholar
• Furneaux HM, Dropcho EJ, Barbut D, Chen YT, Rosenblum MK, Old LJ, Posner JB. 1989. Characterization of a cDNA encoding a 34-kDa Purkinje neuron protein recognized by sera from patients with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci USA. 86:2873–2877. doi: https://doi.org/10.1073/pnas.86.8.2873
   PubMedGoogle Scholar
• Gunbey HP, Bilgici MC, Aslan K, Has AC, Ogur MG, Alhan A, Incesu L. 2017. Structural brain alterations of down's syndrome in early childhood evaluation by DTI and volumetric analyses. Eur Radiol. 27(7):3013–3021. doi: https://doi.org/10.1007/s00330-016-4626-6
   Google Scholar
• Hulten MA, Patel SD, Tankimanova M, Westgren M, Papadogiannakis N, Jonsson AM, et al. 2008. On the origin of trisomy 21 down syndrome. Mol Cytogenet. 1:21. doi: https://doi.org/10.1186/1755-8166-1-21
   PubMedGoogle Scholar
• Jourdy Y, Chatron N, Carage ML, Fretigny M, Meunier S, Zawadzki C, et al. 2016. Study of six patients with complete F9 deletion characterized by cytogenetic microarray: role of the SOX3 gene in intellectual disability. J Thromb Haemost. 14:1988–1993. doi: https://doi.org/10.1111/jth.13430
   Google Scholar
• Kaur R, Sodhi M, Sharma A, Sharma VL, Verma P, Swami SK, et al. 2018. Selection of suitable reference genes for normalization of quantitative RT-PCR(RT-qPCR) expression data across twelve tissues of riverine buffaloes (Bubalus bubalis). PLoS One. 13(3):e0191558. doi: https://doi.org/10.1371/journal.pone.0191558
   PubMed Web of Science ®Google Scholar
• Lejeune J, Gauthier M, Turpin R. 1959. Les chromosomes humains en culture de tissus [Human chromosomes in tissue cultures]. C R Hebd Seances Acad Sci. 248(4):602–603. French. PMID: 13629913.
   Google Scholar
• Letourneau A, Santoni FA, Bonilla X, Sailani MR, Gonzalez D, Kind J, et al. 2014. Domains of genome-wide gene expression dysregulation in down’s syndrome. Nature. 508:345–350. doi: https://doi.org/10.1038/nature13200
   PubMed Web of Science ®Google Scholar
• Li CM, Guo M, Salas M, Schupf N, Silverman W, Zigman WB. 2006. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med Genet. 7:24. doi: https://doi.org/10.1186/1471-2350-7-24
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 22ddct method. Methods. 25:402–408. doi: https://doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Modi BP, Washington S, Walsh SW, Jackson-Cook C, Archer KJ, Strauss JF. 2017. Expression patterns of the chromosome 21 microRNA cluster (miR-99a, miR-125b and let-7c) in chorioamniotic membranes. Placenta. 49:1–9. doi: https://doi.org/10.1016/j.placenta.2016.11.002
   Google Scholar
• Newberger DS. 2000. Down syndrome: prenatal risk assessment and diagnosis. Am Fam Physician. 62:825–832.
   PubMed Web of Science ®Google Scholar
• Olmos-Serrano JL, Kang HJ, Tyler WA, Silbereis JC, Cheng F, Zhu Y, et al. 2016. Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination. Neuron. 89:1208–1222. doi: https://doi.org/10.1016/j.neuron.2016.01.042
   PubMed Web of Science ®Google Scholar
• Pelleri MC, Cattani C, Vitale L, Antonaros F, Strippoli P, Locatelli C, et al. 2018. Integrated quantitative transcriptome maps of human trisomy 21 tissues and cells. Front Genet. 9:125. doi: https://doi.org/10.3389/fgene.2018.00125
   PubMed Web of Science ®Google Scholar
• Ruiz-Zamora RA, Guillaumé S, Al-Hilaly YK, Al-Garawi Z, Rodríguez-Alvarez FJ, Zavala-Padilla G, et al. 2019. The CDR1 and other regions of immunoglobulin light chains are hot spots for amyloid aggregation. Sci Rep. 28:3123. doi: https://doi.org/10.1038/s41598-019-39781-3
   Google Scholar
• Salemi M, Fraggetta F, Galia A, Pepe P, Cimino L, Condorelli RA, Calogero AE. 2014. Cerebellar degeneration-related autoantigen 1 (CDR1) gene expression in prostate cancer cell lines. Int J Biol Markers. 29:e288–e290. doi: https://doi.org/10.5301/jbm.5000062
   Google Scholar
• Salemi M, Giambirtone M, Barone C, Salluzzo MG, Russo R, Giudice ML, et al. 2018. Mitochondrial mRNA expression in fibroblasts of down syndrome subjects. Hum Cell. 31(2):179–181. doi: https://doi.org/10.1007/s13577-018-0205-2
   Google Scholar
• Salemi M, Romano C, Barone C, Calí F, Caraci F, Romano C, Scavuzzo C, Scillato F, Salluzzo MG, Piccione M, et al. 2009. SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in down's syndrome subjects with undescended testes. J Genet. 88(1):93–97. doi: https://doi.org/10.1007/s12041-009-0013-2
   Google Scholar
• Shaw CJ, Lupski JR. 2004. Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease. Hum Mol Genet. 1:R57–R64. doi: https://doi.org/10.1093/hmg/ddh073
   Google Scholar
• Smyth GK. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol.
   PubMedGoogle Scholar
• Sobol M, Klar J, Laan L, Shahsavani M, Schuster J, Annerén G, Konzer A, Mi J, Bergquist J, Nordlund J, et al. 2019. Transcriptome and proteome profiling of neural induced pluripotent stem cells from individuals with down syndrome disclose dynamic dysregulations of key pathways and cellular functions. Mol Neurobiol. 56(10):7113–7127. doi: https://doi.org/10.1007/s12035-019-1585-3
   Google Scholar
• Sullivan KD, Lewis HC, Hill AA, Pandey A, Jackson LP, Cabral JM, et al. 2016. Trisomy 21 consistently activates the interferon response. Elife. 5:e16220. doi: https://doi.org/10.7554/eLife.16220
   PubMed Web of Science ®Google Scholar
• Tang Y, Schapiro MB, Franz DN, Patterson BJ, Hickey FJ, Schorry EK. 2004. Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and down’s syndrome. Ann Neurol. 56:808–814. doi: https://doi.org/10.1002/ana.20291
   PubMed Web of Science ®Google Scholar
• Totland C, Kråkenes T, Mazengia K, Haugen M, Vedeler C. 2018. Expression of the onco neural protein CDR1 in cerebellum and ovarian cancer. Oncotarget. 9:23975–23986. doi: https://doi.org/10.18632/oncotarget.25252
   Google Scholar
• Weick JP, Held DL, Bonadurer GF, Doers ME, Liu Y, Maguire C, et al. 2013. Deficits in human trisomy 21 iPSCs and neurons. Proc Natl Acad Sci USA. 110:9962–9967. doi: https://doi.org/10.1073/pnas.1216575110
   Google Scholar
• Zhao J, Zhang Z, Ren S, Zong Y, Kong X. 2016. Co-expression network analysis of down's syndrome based on microarray data. Exp Ther Med. 12:1503–1508. doi: https://doi.org/10.3892/etm.2016.3462
   Google Scholar